Results 101 to 110 of about 1,394 (181)

Predictive Model for Idiopathic Multicentric Castleman Disease Supporting Treatment Decisions [PDF]

, 2020
Xiaosheng Fang, Zhongling Sun, Zijun Y. Xu‐Monette, Ken H. Young   +3 more
openalex   +1 more source

Interleukin-6 Blockade With Tocilizumab In Idiopathic Multicentric Plasma Cell Variant Castleman Disease: Case report [PDF]

, 2023
Fernando Naranjo-Saltos, Martin Lescano, Yanael Arce, Heidi Ángela Fernández   +3 more
openalex   +1 more source

Utility of renal biopsy in differentiating idiopathic multicentric Castleman disease from IgG4-related disease [PDF]

, 2022
Miharu Kawanishi, Fumika Kamei, Hirotaka Sonoda, Masafumi Oba, Shohei Fukunaga, Masahiro Egawa, Takashi Koyama, Yasuharu Sato, Kazuaki Tanabe, Takafumi Ito   +9 more
openalex   +1 more source

Successful treatment with bortezomib in combination with dexamethasone in a middle-aged male with idiopathic multicentric Castleman’s disease: A case report

Open Medicine
Multicentric Castleman disease (MCD) is a heterogeneous, life-threatening disease. A subgroup of HIV-negative and HHV-8-negative MCD is defined as idiopathic MCD (iMCD) with a poor prognosis.
Li Hongling, He Yang, Wang Yongying, Xu Mengwei   +3 more
doaj   +1 more source

Evolution of Pulmonary Involvement in Idiopathic Multicentric Castleman Disease-Not Otherwise Specified [PDF]

, 2023
Jiamin Zhou, Lu Zhang, Xueqing Liu, Miaoyan Zhang, Li J, Weihong Zhang   +5 more
openalex   +1 more source

Multicentric Castleman disease presenting with orbital involvement progressing to TAFRO syndrome: a case report

BMC Ophthalmology
Background Castleman Disease (CD) can be unicentric or multicentric, with the ocular involvement rare; notably, the aggressive TAFRO syndrome (TS) is a subtype of idiopathic multicentric CD (iMCD). Ocular involvement in CD is rare, and to date, there are
Yuanfeng Wei, Jing Qi, Jiawei Yan, Guangjian Gao, Xinyue Ji, Danning Yu, Wanru Chen, Dongping Huang   +7 more
doaj   +1 more source

Idiopathic multicentric Castleman disease preceded by cutaneous plasmacytosis successfully treated by tocilizumab [PDF]

, 2020
Tetsuro Aita, Sugihiro Hamaguchi, Yoko Shimotani, Yohei Nakamoto   +3 more
openalex   +1 more source

A Rare Variant of Idiopathic Multicentric Castleman Disease: TAFRO Syndrome

Turkish Journal of Hematology, 2022
Ece Ük, Alper Akın, Übeyde Ayşe Gülseren, Simge Erdem, Alpay Medetalibeyoğlu   +4 more
doaj   +1 more source

Tacrolimus Treatment for TAFRO Syndrome

Biomedicines
TAFRO syndrome is an acute systemic inflammatory disorder characterized by thrombocytopenia, anasarca, fever, reticulin myelofibrosis, renal dysfunction, and organomegaly.
Taiichiro Shirai, Shinya Ichikawa, Jun Saegusa   +2 more
doaj   +1 more source

888 | HEALTHCARE RESOURCE UTILIZATION AND COSTS IN THE MANAGEMENT OF PATIENTS WITH IDIOPATHIC MULTICENTRIC CASTLEMAN DISEASE IN THE UNITED STATES [PDF]

Ariela Noy, Robert S. Ohgami, Nikhil C. Munshi, Imran Siddiqi, J. Cai, Kelley Dacus, Alicia Watson Saltis, F. Shupo, Nicole Princic, Kristin Evans, S. Mukherjee   +10 more
openalex   +1 more source